Abstract B027: Combining Total Cell-Free DNA (cfdna) and Circulating Tumor (ctdna) to Enhance the Clinical Sensitivity of Ddpcr Assays to Detect Minimal Residual Disease (MRD) in Stage IIIB/C/IV Melanoma Patients on Adjuvant Immunotherapy in CheckMate 238
Clinical Cancer Research（2024）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined